Eiger BioPharmaceuticals, Inc. EIGRQ
8.50
0.00
0.00%
as of 1 Oct
- Market cap
- $2.6M
- P/E
- 0.0×
Follow EIGRQ
Growth Flags
show if company had growth for consecutive years
| Dec '23 | Sep '23 | Jun '23 | Mar '23 | Older periods | |
|---|---|---|---|---|---|
| (367.00%) | (225.93%) | (161.95%) | (146.28%) |
+8 more TTM periods Free account |
|
| (94.31%) | (86.91%) | (81.11%) | (76.75%) | ||
ROIC |
(3,674.55%) | 0.00% | (2,469.33%) | (14,894.98%) | |
Return on Tangible Assets |
505.89% | (223.45%) | (175.56%) | (131.47%) | |
Average Days of Receivables |
38.92 | 32.88 | 87.59 | 95.13 | |
Free Cash Flow per Share |
(50.67) | (56.44) | (60.61) | (60.62) | |
Free Cash Flow |
(74.78) | (83.30) | (89.41) | (89.11) | |
Capital Expenditures |
(0.23) | (0.46) | (0.56) | (0.56) | |
Piotroski F-Score |
3.00 | 3.00 | 2.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(143.08%) | (105.19%) | (81.08%) | (58.67%) | |
Accounts Receivable Turnover |
9.19 | 7.76 | 6.51 | 4.83 | |
Accounts Payable Turnover |
0.00 | 0.03 | 0.19 | 0.18 | |
Inventory Turnover |
0.01 | 0.14 | 0.70 | 0.51 | |
Average Days of Payables |
32,165.63 | 6,616.31 | 1,304.40 | 2,345.89 | |
Days of Inventory on Hand |
23,664.17 | 1,504.94 | 289.57 | 1,056.03 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
395.18% | 472.10% | 496.53% | 498.76% | |
Selling, General and Administrative Expense of Revenue |
159.79% | 196.39% | 195.81% | 213.06% | |
Share Based Compensation of Revenue |
31.75% | 42.04% | 47.47% | 59.03% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.99 | 0.96 | 0.93 | 0.91 | |
Depreciation/Fixed assets |
(1.33) | (1.14) | (0.50) | 0.34 | |
Capex/Depreciation |
0.28 | 0.59 | 1.51 | (2.05) | |
Revenue per Share |
10.69 | 9.94 | 10.49 | 10.16 | |
Operating CF per Share |
(50.51) | (56.13) | (60.23) | (60.24) | |
Capex per Share |
(0.16) | (0.31) | (0.38) | (0.38) | |
Capex to Sales |
0.01 | 0.03 | 0.04 | 0.04 | |
Net Profit Margin |
(475.26%) | (590.80%) | (618.36%) | (649.19%) |
Columns are period end dates